Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from DHR

5 Top Mega-Cap Stocks in the Healthcare Sector to Buy This Month

The healthcare sector is known for its defensive qualities. Therefore, betting on mega-cap healthcare stocks could be one of the best ways to generate stable returns amid the current, extended, market volatility. We think their solid growth attributes and profit margins make the stocks of Novartis (NVS), Danaher (DHR), Eli…

Here's How Much You Would Have Made Owning Danaher Stock In The Last 15 Years

Here's How Much You Would Have Made Owning Danaher Stock In The Last 15 Years

Danaher (NYSE:DHR) has outperformed the market over the past 15 years by 7.23% on an annualized basis producing an average annual return of 15.22%. Currently, Danaher has a market capitalization of $212.45 billion.

Looking At Danaher's Recent Whale Trades

Looking At Danaher's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Danaher (NYSE:DHR). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

5 No-Brainer Growth Stocks to Buy During the Market Correction

The stock market has been exhibiting immense volatility of late due to escalating economic sanctions on Russia in response to its invasion of Ukraine, inflationary pressures, and supply chain disruptions. However, some growth-focused companies should be able to capitalize on the steady economic recovery this year. Microsoft (MSFT), Alphabet (GOOGL),…

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much

Danaher (NYSE:DHR) has outperformed the market over the past 20 years by 7.58% on an annualized basis.

Thermo Fisher Scientific vs. Danaher: Which Diagnostics & Research Stock is a Better Buy?

Rising demand for advanced diagnostic devices for predicting the early development of diseases and getting accurate results within less time should drive the diagnostics and research industry’s growth. Given the rising investments in the industry, prominent players in this space, Thermo Fisher (TMO) and Danaher (DHR) should benefit. But which…

Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years

Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 8.65% on an annualized basis.

inkl

Read news from The Economist, FT, and more,
with one subscription

Where Danaher Stands With Analysts

Where Danaher Stands With Analysts

Within the last quarter, Danaher (NYSE:DHR) has observed the following analyst ratings:

Danaher Q4 Results Beat Expectations, Clocks 21% Jump In Sales

Danaher Q4 Results Beat Expectations, Clocks 21% Jump In Sales

Danaher Corporation (NYSE: DHR)

Danaher's Earnings Outlook

Danaher's Earnings Outlook

Danaher (NYSE:DHR) is set to give its latest quarterly earnings report on Thursday, 2022-01-27. Here's what investors need to know before the announcement. Analysts estimate that Danaher will likely report an Earnings Per Share (EPS) of $2.51.

Organisations

Abbott Laboratories

Eli Lilly and Company

KLA Corporation

rmo Fisher Scientific

Danaher Corporation

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play